273 related articles for article (PubMed ID: 25408104)
1. Apparent diffusion coefficient ratio correlates significantly with prostate cancer gleason score at final pathology.
Boesen L; Chabanova E; Løgager V; Balslev I; Thomsen HS
J Magn Reson Imaging; 2015 Aug; 42(2):446-53. PubMed ID: 25408104
[TBL] [Abstract][Full Text] [Related]
2. Apparent Diffusion Coefficient (ADC) Ratio Versus Conventional ADC for Detecting Clinically Significant Prostate Cancer With 3-T MRI.
Bajgiran AM; Mirak SA; Sung K; Sisk AE; Reiter RE; Raman SS
AJR Am J Roentgenol; 2019 Sep; 213(3):W134-W142. PubMed ID: 31216201
[No Abstract] [Full Text] [Related]
3. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
4. Quantitative evaluation of the relative apparent diffusion coefficient values on multiparametric magnetic resonance imaging to predict higher Gleason score prostate cancer.
Kato S; Kamijima S; Inaoka T; Kamiya N; Sasai D; Terada H; Hiruta N; Suzuki H
Scand J Urol; 2018 Jun; 52(3):180-185. PubMed ID: 29939084
[TBL] [Abstract][Full Text] [Related]
5. Apparent diffusion coefficient for prostate cancer imaging: impact of B values.
Peng Y; Jiang Y; Antic T; Sethi I; Schmid-Tannwald C; Eggener S; Oto A
AJR Am J Roentgenol; 2014 Mar; 202(3):W247-53. PubMed ID: 24555621
[TBL] [Abstract][Full Text] [Related]
6. Non-Gaussian water diffusion kurtosis imaging of prostate cancer.
Suo S; Chen X; Wu L; Zhang X; Yao Q; Fan Y; Wang H; Xu J
Magn Reson Imaging; 2014 Jun; 32(5):421-7. PubMed ID: 24602826
[TBL] [Abstract][Full Text] [Related]
7. Diffusion-weighted MRI as a predictor of extracapsular extension in prostate cancer.
Kim CK; Park SY; Park JJ; Park BK
AJR Am J Roentgenol; 2014 Mar; 202(3):W270-6. PubMed ID: 24555624
[TBL] [Abstract][Full Text] [Related]
8. Apparent diffusion coefficient value and ratio as noninvasive potential biomarkers to predict prostate cancer grading: comparison with prostate biopsy and radical prostatectomy specimen.
De Cobelli F; Ravelli S; Esposito A; Giganti F; Gallina A; Montorsi F; Del Maschio A
AJR Am J Roentgenol; 2015 Mar; 204(3):550-7. PubMed ID: 25714284
[TBL] [Abstract][Full Text] [Related]
9. Utility of diffusional kurtosis imaging as a marker of adverse pathologic outcomes among prostate cancer active surveillance candidates undergoing radical prostatectomy.
Rosenkrantz AB; Prabhu V; Sigmund EE; Babb JS; Deng FM; Taneja SS
AJR Am J Roentgenol; 2013 Oct; 201(4):840-6. PubMed ID: 24059373
[TBL] [Abstract][Full Text] [Related]
10. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Evaluation of Prostate Cancer Aggressiveness: Using ADC and ADC Ratio in Determining Gleason Score.
Woo S; Kim SY; Cho JY; Kim SH
AJR Am J Roentgenol; 2016 Jul; 207(1):114-20. PubMed ID: 27077643
[TBL] [Abstract][Full Text] [Related]
13. Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
Gibbs P; Liney GP; Pickles MD; Zelhof B; Rodrigues G; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):572-6. PubMed ID: 19692841
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of apparent diffusion coefficient (ADC) values in patients with prostate cancer: can ADC values contribute to assess the aggressiveness of prostate cancer?
Itou Y; Nakanishi K; Narumi Y; Nishizawa Y; Tsukuma H
J Magn Reson Imaging; 2011 Jan; 33(1):167-72. PubMed ID: 21182135
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric magnetic resonance imaging for the assessment of extracapsular invasion and other staging parameters in patients with prostate cancer candidates for radical prostatectomy.
Lista F; Gimbernat H; Cáceres F; Rodríguez-Barbero JM; Castillo E; Angulo JC
Actas Urol Esp; 2014 Jun; 38(5):290-7. PubMed ID: 24387827
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of apparent diffusion coefficient values obtained using high b-value when diagnosing prostate cancer using 3 tesla MRI: comparison between ultra-high b-value (2000 s/mm²) and standard high b-value (1000 s/mm²).
Kitajima K; Takahashi S; Ueno Y; Yoshikawa T; Ohno Y; Obara M; Miyake H; Fujisawa M; Sugimura K
J Magn Reson Imaging; 2012 Jul; 36(1):198-205. PubMed ID: 22371381
[TBL] [Abstract][Full Text] [Related]
17. Does normalisation improve the diagnostic performance of apparent diffusion coefficient values for prostate cancer assessment? A blinded independent-observer evaluation.
Rosenkrantz AB; Khalef V; Xu W; Babb JS; Taneja SS; Doshi AM
Clin Radiol; 2015 Sep; 70(9):1032-7. PubMed ID: 26126712
[TBL] [Abstract][Full Text] [Related]
18. Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging.
Liu X; Zhou L; Peng W; Wang C; Wang H
Magn Reson Imaging; 2013 Oct; 31(8):1318-24. PubMed ID: 23791546
[TBL] [Abstract][Full Text] [Related]
19. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient.
Donati OF; Mazaheri Y; Afaq A; Vargas HA; Zheng J; Moskowitz CS; Hricak H; Akin O
Radiology; 2014 Apr; 271(1):143-52. PubMed ID: 24475824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
